For decades, treatment for cancer was a blunt tool — everyone got the same, left to fight for their life chances against sometimes impossible odds. That is changing. Today, a breakthrough at a London research lab could lead to personalised treatments — in this case for advanced breast cancer.
Scientists at The Institute of Cancer Research, in conjunction with academics from Oxford and Cambridge, have discovered the key features of immune B cells which help them to target tumours — even when cancer has spread to a different part of the body. Identifying these anti-cancer immune cells raises the possibility of improved and, critically, personalised treatment to boost the body’s immune system’s response against breast cancer that has spread.
